NCT01857830

Brief Summary

The purpose of this research study is to examine whether a short term meditation intervention can improve health, mood, and biological markers of cellular stress and aging in novice and experienced meditators compared to controls.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
96

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2013

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2013

Completed
24 days until next milestone

First Submitted

Initial submission to the registry

April 25, 2013

Completed
25 days until next milestone

First Posted

Study publicly available on registry

May 20, 2013

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2013

Completed
Last Updated

August 21, 2013

Status Verified

August 1, 2013

Enrollment Period

3 months

First QC Date

April 25, 2013

Last Update Submit

August 19, 2013

Conditions

Keywords

TelomeraseTelomere LengthPsychological StressAmyloid beta proteinsMeditation

Outcome Measures

Primary Outcomes (1)

  • Telomerase

    Participants blood will be drawn by licensed phlebotomist on the day after their arrival at La Costa Resort at their baseline assessment and again 96 hours later at their follow-up assessment. Telomerase will be measured at both time points.

    Change from Baseline in Telomerase 96 hours later

Secondary Outcomes (5)

  • Amyloid Beta Proteins

    Change from baseline in Amyloid Beta Proteins, 96 hours later

  • Psychological Well being

    Change from Baseline in psychological well being at 96 hours, and 1 month later.

  • Oxytocin

    Change from baseline in Oxytocin at 96 hours later.

  • Telomere Length

    Change from Baseline in Telomere Length, 96 hours later

  • Gene Expression

    Change from Baseline in Gene Expression, 96 hours later

Study Arms (2)

Meditation Retreat Group

EXPERIMENTAL

Participants in this group will participate in a 6 day meditation retreat at the La Costa Resort and Spa in Carlsbad, CA. They will be self-selected to participate in the retreat or are novice meditators randomized into this retreat.

Behavioral: Meditation Retreat

Relaxation/Control Group

ACTIVE COMPARATOR

Participants in this group will stay at La Costa Resort and spa for a 6 day period and will participate in the Active Comparator Relaxation Group activities (i.e. series of lectures on longevity and health, shared meals, and other leisure activities).

Behavioral: Active Comparator Relaxation Group

Interventions

The intervention is a one week meditation and yoga retreat hosted at the La Costa Resort and Spa in Carlsbad, CA.

Meditation Retreat Group

Participants are randomized to stay at La Costa Resort and Spa for 6 days. Participants will receive daily meals similar to the meals for those in the retreat group. Participants will also receive a daily one hour lecture on topics related to longevity and health.

Relaxation/Control Group

Eligibility Criteria

Age30 Years - 60 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy
  • Women
  • Age 30-60
  • "Novice Meditator" (meditates for 30 minutes per week or less) or "Experienced Meditator" (meditates at 40 or more per week and for more than 6 months, and are self-selected/enrolled in the retreat)

You may not qualify if:

  • Current or history of a major medical condition (such as cancer, heart disease, autoimmune disease, diabetes)
  • Smokers (have not smoked regularly for the past 6 months)
  • Currently taking antidepressants
  • Post Traumatic Stress Disorder
  • Currently taking Hormone Replacement Therapy or birth control pills

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chopra Center for Wellbeing

Carlsbad, California, 92009, United States

Location

MeSH Terms

Conditions

Stress, PsychologicalPlaque, Amyloid

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Elissa Epel, PhD

    University of California, San Francisco

    PRINCIPAL INVESTIGATOR
  • Eli Puterman, PhD

    University of California, San Francisco

    PRINCIPAL INVESTIGATOR
  • Elizabeth Blackburn, PhD

    University of California, San Francisco

    PRINCIPAL INVESTIGATOR
  • Jue Lin, PhD

    University of California, San Francisco

    PRINCIPAL INVESTIGATOR
  • Samantha Schilf, BA

    University of California, San Francisco

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 25, 2013

First Posted

May 20, 2013

Study Start

April 1, 2013

Primary Completion

July 1, 2013

Study Completion

July 1, 2013

Last Updated

August 21, 2013

Record last verified: 2013-08

Locations